Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$3.47 - $6.32 $223,707 - $407,444
-64,469 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$5.36 - $7.24 $111,316 - $150,360
20,768 Added 47.52%
64,469 $345,000
Q4 2018

Feb 12, 2019

SELL
$4.8 - $11.6 $7,804 - $18,861
-1,626 Reduced 3.59%
43,701 $224,000
Q3 2018

Nov 14, 2018

SELL
$9.05 - $10.95 $905 - $1,095
-100 Reduced 0.22%
45,327 $439,000
Q2 2018

Aug 14, 2018

BUY
$10.2 - $13.9 $174,124 - $237,286
17,071 Added 60.2%
45,427 $463,000
Q1 2018

May 16, 2018

BUY
$12.65 - $18.85 $358,703 - $534,510
28,356 New
28,356 $368,000

Others Institutions Holding PRTK

About Paratek Pharmaceuticals, Inc.


  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Old West Investment Management, LLC Portfolio

Follow Old West Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old West Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old West Investment Management, LLC with notifications on news.